CA
ALT icon

Cetera Advisors’s Altimmune ALT Stock Holding History

Cetera Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$619K Buy
60,800
+9,977
+20% +$101K ﹤0.01% 1465
2023
Q4 		$572K Buy
+50,823
New +$212K 0.01% 1048
2023
Q1 		– Sell
-10,100
Closed -$166K – 1652
2022
Q4 		$166K Sell
10,100
-2,300
-19% -$25.8K ﹤0.01% 1468
2022
Q3 		$158K Sell
12,400
-4,700
-27% -$69.4K ﹤0.01% 1170
2022
Q2 		$200K Sell
17,100
-1,400
-8% -$8.63K ﹤0.01% 1242
2022
Q1 		$113K Buy
+18,500
New +$136K ﹤0.01% 1351

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cetera Advisors's ALT Position: Q1 2024 in Review

Cetera Advisors increased its Altimmune (ALT) stake by 20% in Q1 2024, buying an estimated $101K and bringing the position to 60,800 shares worth $619K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Cetera Advisors first reported a position in ALT in Q1 2022 and has held it in 6 quarters since. 172 funds tracked by Wall St. Rank hold ALT as of Q1 2024.

  • Cetera Advisors held 60,800 shares of Altimmune worth $619K as of Q1 2024.
  • Cetera Advisors bought 9,977 Altimmune shares in Q1 2024, an estimated $101K.
  • Altimmune made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1465 holding.
  • Cetera Advisors first reported a position in Altimmune in Q1 2022 and has held it in 6 quarters since.
  • 172 funds tracked by Wall St. Rank held Altimmune as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.